slide1 n.
Skip this Video
Download Presentation
How profitable is it to invest in NASH market?

Loading in 2 Seconds...

play fullscreen
1 / 12

How profitable is it to invest in NASH market? - PowerPoint PPT Presentation

  • Uploaded on

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'How profitable is it to invest in NASH market?' - alliedmarketresearch

Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

75 Pages Report

Published Date : Aug - 2014



Table of Content


Executive Summary

Global 3D Technology Market Overview

Global 3D Technology Market by Products

Global 3D Technology Market by Applications

Global 3D Technology Market by Geography

Company Profiles

Key Audiences

Scope of the Report

Key Benefits



Nonalcoholic Steatohepatitis (NASH) also known as “silent disease” is a type of fatty liver disease, which mainly affects people with diabetes and obesity. Symptoms of NASH are found among all demographics (from children to adults); however, they are more prevalent in younger people. Corner stage of cirrhosis is a form of NASH that can be reversed with proper medication. Moreover, most of the NASH specific pharmaceutical solution are in clinical trial phase . Additionally, the absence of efficient diagnostic technologies acts as a major hurdle for the research of NASH therapeutics. Nevertheless, the emergence of novel biomarker technologies and improvements in liver biopsy technologies are expected to bring about an evolution in the diagnosis of NASH and other fatty liver diseases. Global non-alcoholic Steatohepatitis market is expected to garner $1693.2 million by 2020 growing at a CAGR of 25.6% during 2014-2020.

Increase in cycles of clinical trials and their success rate has increased the probability of industries receiving commercial approval for NASH therapeutics by the end of 2017. The market growth is restricted by factors such as NASH’s complex and enigmatic physiological structure and inefficient diagnostics technology; these factors could also prolong the commercialization process for NASH therapeutics.



  • Various opportunities for non alcoholic fatty liver disease therapeutics present in developed as well as developing economies are thoroughly assessed
  • Substitute treatments and their potential impact on NASH therapeutics are strategically quantified in the report
  • Opportunities from a business perspective latent in the Asia-Pacific region are brought to light
  • Market dimensions of diagnostic techniques used in NASH monitoring provide a clear outline of the NASH therapeutics research market
  • Geography-wise segmentation of clinical trials is conducted to provide strategic intelligence to the stakeholder
  • Pipeline analysis for the key NASH therapeutics under clinical research provides market intelligence needed for commercialization
  • Detailed analysis of market dynamics provides intelligence about market competencies according to segments
  • In depth analysis of key players operating in the fatty liver disease therapeutics market is conducted according to regions

Table of Contents


Executive Summary

Market Beyond: What To Expect By 2025

Market Overview

5. Global Nonalcoholic Steatohepatitis Market By Drug Types

6. Global Nonalcoholic Steatohepatitis Market

7. Company Profiles


Nonalcoholic Steatohepatitis Market Overview

Market Definition

Key Findings

Impeding opportunities for NASH


Nonalcoholic Steatohepatitis Market Overview

Incongruity about preventative role of Fructose

Diagnostic Techniques

Prevalence of nonalcoholic fatty liver disease

Dos and Don’ts For Nonalcoholic Fatty Liver Disease


Market Dynamics

  • Market Dynamics

Your feedback is important to us

What would you like to know more about this Study ?

  • Global Industry Analysis
  • Market Size
  • Market Share
  • Market Trends
  • Opportunities and Forecast
  • Key Market Drivers



Rampant rate of obesity and diabetes globally

Acceleration in initiatives for research and development activities



Blurred understanding of pathophysiology of NASH

Please inform us on :

Inefficient diagnostic technology for NASH

Slower development of therapeutics for NASH


Global Nonalcoholic Steatohepatitis Market By Drug Types


Obeticholic Acid (INT-747)

Global Nonalcoholic Steatohepatitis Market By Drug Types

Simtuzumab and Liraglutide (Victoza)

Vitamin E



Top Market Players of Nonalcoholic Steatohepatitis (NASH) Market 

  • Genfit.
  • Gilead Science
  • Novo Nordisk
  • Intercepts Pharmaceuticals
  • Enzo Biochem, Inc.
  • Raptor Pharmaceutical Corp.

Your feedback is important to us

What would you like to know more about this Study ?

  • Global Industry Analysis
  • Market Size
  • Market Share
  • Market Trends
  • Opportunities and Forecast

Please inform us on :